Wolfgang Schuermann

in patients with COPD Effect on lung function and morning activities of budesonide / formoterol versus salmeterol / fluticasone

M. Partridge, T. Persson, T. Polanowski, 2009 .

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study

S. Korn, R. Buhl, C. Gessner, 2015, Thorax.

Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD

M. Partridge, T. Persson, T. Polanowski, 2009, Therapeutic advances in respiratory disease.

Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers.

W. Thilly, D. Olson, J. Willey, 1997, American journal of respiratory cell and molecular biology.